Literature DB >> 8862300

Gastric emptying in early noninsulin-dependent diabetes mellitus.

K L Jones1, M Horowitz, B I Carney, J M Wishart, S Guha, L Green.   

Abstract

UNLABELLED: The aims of this study were to determine in early noninsulin-dependent diabetes mellitus (NIDDM): (a) the prevalence of disordered gastric emptying of glucose; (b) the relationship between the blood glucose response to an oral glucose load and gastric emptying; and (c) the relationship between appetite and gastric emptying.
METHODS: Sixteen patients (ages 39-79 yr) with recently diagnosed NIDDM consumed 350 ml water containing 75 g glucose and 99mTc-sulfur colloid while sitting in front of a gamma camera. Blood glucose concentrations were monitored immediately before and after the drink. Hunger and fullness were evaluated using visual analog scales. The results were compared to those obtained in 13 normal subjects of similar age and body mass index. All patients and control subjects were white and non-Hispanic.
RESULTS: Gastric emptying was slightly slower in the NIDDM patients when compared to the control subjects (retention at 180 min 15.9 +/- 2.3% versus 3.8 +/- 1.0%, p < 0.001), but there was no significant difference in the 50% emptying time between the two groups. In the NIDDM patients, there was an inverse relationship between the magnitude of the increase in the blood glucose concentration and gastric emptying, e.g., between the area under the curve for blood glucose from 0-60 min and the intragastric retention of the drink at 60 min (r = -0.60, p < 0.05). In the NIDDM patients, fullness was greater (p < 0.005) both before and after the drink, and the score for hunger at 30 min was inversely related to the rate of gastric emptying (r = -0.52, p < 0.05).
CONCLUSION: In patients with early NIDDM, gastric emptying of 75 g glucose is similar to that of normal subjects and is a significant determinant of the glycemic response.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8862300

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  52 in total

1.  Hypoglycemic effects of intraluminal intestinal electrical stimulation in healthy volunteers.

Authors:  Jinsong Liu; Yifei Xiang; Xian Qiao; Yu Dai; Jiande D Z Chen
Journal:  Obes Surg       Date:  2011-02       Impact factor: 4.129

Review 2.  Whey protein: The "whey" forward for treatment of type 2 diabetes?

Authors:  Linda E Mignone; Tongzhi Wu; Michael Horowitz; Christopher K Rayner
Journal:  World J Diabetes       Date:  2015-10-25

3.  Effects of posture on gastric emptying, transpyloric flow, and hunger after a glucose drink in healthy humans.

Authors:  Karen L Jones; Deirdre O'Donovan; Michael Horowitz; Antonietta Russo; Yong Lei; Trygve Hausken
Journal:  Dig Dis Sci       Date:  2006-07-13       Impact factor: 3.199

Review 4.  An update on autonomic neuropathy affecting the gastrointestinal tract.

Authors:  Liza K Phillips; Christopher K Rayner; Karen L Jones; Michael Horowitz
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

5.  To be or not to be--an incretin or enterogastrone?

Authors:  M Horowitz; M A Nauck
Journal:  Gut       Date:  2006-02       Impact factor: 23.059

Review 6.  Diabetic gastroparesis: what we have learned and had to unlearn in the past 5 years.

Authors:  Purna Kashyap; Gianrico Farrugia
Journal:  Gut       Date:  2010-09-25       Impact factor: 23.059

Review 7.  Pathophysiology and management of diabetic gastropathy: a guide for endocrinologists.

Authors:  Paul Kuo; Christopher K Rayner; Karen L Jones; Michael Horowitz
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 8.  Mechanisms of surgical control of type 2 diabetes: GLP-1 is the key factor-Maybe.

Authors:  Marzieh Salehi; David A D'Alessio
Journal:  Surg Obes Relat Dis       Date:  2016-05-11       Impact factor: 4.734

9.  Glucose absorption and gastric emptying in critical illness.

Authors:  Marianne J Chapman; Robert J L Fraser; Geoffrey Matthews; Antonietta Russo; Max Bellon; Laura K Besanko; Karen L Jones; Ross Butler; Barry Chatterton; Michael Horowitz
Journal:  Crit Care       Date:  2009-08-27       Impact factor: 9.097

10.  Incretin-based therapies: new treatments for type 2 diabetes in the new millennium.

Authors:  Joan Khoo; Christopher K Rayner; Karen L Jones; Michael Horowitz
Journal:  Ther Clin Risk Manag       Date:  2009-08-20       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.